EARLY BIRD REGISTRATION ENDS SEPTEMBER 1!
![shutterstock_2658171737 [Converted]_Smaller.jpg](https://static.wixstatic.com/media/dcb143_8063f21dfa5b4fe6890ff40ca69c3d51~mv2.jpg/v1/fill/w_980,h_327,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/dcb143_8063f21dfa5b4fe6890ff40ca69c3d51~mv2.jpg)
Member Spotlight
Mechele Fillman, NP
Mechele Fillman, NP, is a nationally recognized pain management specialist with more than 20 years of experience in acute and chronic pain care across leading academic and community medical centers. Dual-certified in Geriatric Nursing and Pain Management, she currently serves at Christus St. Vincent Regional Medical Center, where she has helped develop advanced inpatient pain management services and protocols. In addition to her clinical leadership, Mechele is an accomplished speaker, educator, and mentor who has contributed to publications, policy development, and interdisciplinary training. Outside of medicine, she is actively involved in search and rescue work with her German Shepherds through New Mexico Working K9s.
.png)
INDUSTRY NEWS
Will recent FDA approval of a novel
nonopioid analgesic be a game changer?
Physician's Weekly
The Food and Drug Administration recently approved Journavx, a first-in-class oral, nonopioid, highly selective sodium channel blocker indicated as a treatment for adults with moderate to severe acute pain. Clinical data revealed that this agent is an effective, well-tolerated medicine without evidence of addictive potential, indicated for use with all types of moderate to sever acute pain.
